signs and symptoms, gets on well with family, gets on well with the community, and pays income tax. Up to 90% of early patients, not yet badly damaged by the illness and the way it was treated, will achieve this. With chronic patients most will achieve this after 6 or 7 years of treatment. The treatment has been described many times. Literature is available from the Canadian Schizophrenia Foundation, 16 Florence Avenue, Toronto, Canada M2N 1E9, telephone number, fax number. I am pleased with my medical colleagues who are quickly moving into this modern paradigm, and am very frustrated by the massive inertia of my psychiatric colleagues who are still waiting for the Holy Grail, that new tranquilizer which appears every year, which will do for schizophrenia what insulin does for diabetes. The number of homeless chronic schizophrenics in the streets of all large American and Canadian cities is evidence of their inability to do more them than we could do in 1950 before we had any tranquilizers. But at least then we had hospitals which provided shelter and food and some care. Today the downtown slums have become the surrogate mental hospital beds for the chronic patients whose treatment has been wholly tranquilizers. About thirty years ago I predicted that it would take at least forty years before megavitamin treatment would be accepted. After all, Moses walked his Israelite followers in circles in the desert for 40 years before initiating the invasion of the Holy Land. He realized that two generations of people born and raised in slavery would have to die before he could depend upon them to have enough fighting spirit and spunk to attempt the invasion. Do we have to wait for more than two generations of psychiatrists bred in the analytic and tranquilizer era to die before their offspring can begin to think about orthomolecular treatment of schizophrenic patients? Our first megavitamin treatment paper was published in 1957. Abram Hoffer (1917) e uma psiquiatra canadense, conhecido pelo seu trabalho no desenvolvimento de terapias bioquimicas basedas no uso da nutricao e vitaminas no tratamento da esquizofrenia, Esta terapia e conhecida pelo nome de psiquiatria ortomolecular. A abordagem geral, denominada Medicina Ortomolecular, inclui o uso de megavitaminas.Ligacoes externasAbram Hoffer - Biografia - HealthWorld OnlinePagina Pessoal - Orthomolecular Treatment of CancerEntrevista com Abram HofferBob Wipond interviews Abram HofferEwan Cameron Ewan Cameron (31 de Julho de 1922 - 21 de Marco de 1991) foi um medico, nascido em Glasgow, na Escocia. Trabalhou com Linus Pauling em investigacoes sobre a vitamina C. Recebeu a sua graduacao pela Universidade de Glasgow em 1944, e imediatamente a seguir juntou-se ao Exercito Britanico, tendo desempenhado funcoes medicas, por tres anos, em Myanmar. Trabalhou para o Hospital Vale of Leven, em Dunbartonshire, na Escocia, de 1956 ate 1984.Recebeu a Queen's Coronation Medal em 1977, assim como fellowships pelo Royal Colleges of Surgeons in Glasgow and Edinburgh e pelo Royal Faculty of Physicians and Surgeons in Glasgow. Em 1966, Cameron publicou oseu primeiro livro, intitulado Hyaluronidase and Cancer (Hialuronidase e Cancro).Em 1971, Cameron comecou a corresponder-se com